

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.92668443 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.71570257 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.54829732 |
| 4 | regulation of ARF GTPase activity (GO:0032312) | 4.51934207 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.33593499 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33593499 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.65135059 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.64529559 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54885760 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 3.43726626 |
| 11 | detection of bacterium (GO:0016045) | 3.42358065 |
| 12 | detection of other organism (GO:0098543) | 3.40846461 |
| 13 | mannose metabolic process (GO:0006013) | 3.39941333 |
| 14 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.39480280 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.31862868 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 3.27917191 |
| 17 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.26840084 |
| 18 | germinal center formation (GO:0002467) | 3.22259496 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.19304544 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.19304544 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.19304544 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.19304544 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.19304544 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.19304544 |
| 25 | histone H3-K9 demethylation (GO:0033169) | 3.14682584 |
| 26 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13677662 |
| 27 | response to peptidoglycan (GO:0032494) | 3.05661137 |
| 28 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.00499762 |
| 29 | histone H4 deacetylation (GO:0070933) | 2.99532904 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92778326 |
| 31 | NIK/NF-kappaB signaling (GO:0038061) | 2.92647573 |
| 32 | detection of external biotic stimulus (GO:0098581) | 2.92056814 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.91760928 |
| 34 | negative regulation of type 2 immune response (GO:0002829) | 2.90959554 |
| 35 | regulation of ARF protein signal transduction (GO:0032012) | 2.89215777 |
| 36 | leukocyte aggregation (GO:0070486) | 2.83239435 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77873732 |
| 38 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75051312 |
| 39 | response to type I interferon (GO:0034340) | 2.73562470 |
| 40 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.73314926 |
| 41 | type I interferon signaling pathway (GO:0060337) | 2.71919650 |
| 42 | cellular response to type I interferon (GO:0071357) | 2.71919650 |
| 43 | signal complex assembly (GO:0007172) | 2.70567689 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69673129 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 2.69597145 |
| 46 | positive regulation of histone deacetylation (GO:0031065) | 2.69561490 |
| 47 | regulation of leukocyte degranulation (GO:0043300) | 2.67792559 |
| 48 | detection of molecule of bacterial origin (GO:0032490) | 2.66853861 |
| 49 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66389707 |
| 50 | positive regulation of protein kinase C signaling (GO:0090037) | 2.65329849 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 2.65045098 |
| 52 | regulation of type 2 immune response (GO:0002828) | 2.61973798 |
| 53 | positive regulation of Rap GTPase activity (GO:0032854) | 2.61588891 |
| 54 | cellular extravasation (GO:0045123) | 2.61072393 |
| 55 | semaphorin-plexin signaling pathway (GO:0071526) | 2.60191432 |
| 56 | thymic T cell selection (GO:0045061) | 2.59401860 |
| 57 | epithelial structure maintenance (GO:0010669) | 2.59202269 |
| 58 | positive regulation of type 2 immune response (GO:0002830) | 2.56267448 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.55028840 |
| 60 | activation of Rac GTPase activity (GO:0032863) | 2.53148236 |
| 61 | histone H3 deacetylation (GO:0070932) | 2.52847969 |
| 62 | positive thymic T cell selection (GO:0045059) | 2.52592664 |
| 63 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51886824 |
| 64 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48112771 |
| 65 | detection of biotic stimulus (GO:0009595) | 2.45490155 |
| 66 | neutrophil activation (GO:0042119) | 2.45174343 |
| 67 | regulation of necroptotic process (GO:0060544) | 2.43447361 |
| 68 | negative regulation of myotube differentiation (GO:0010832) | 2.42483534 |
| 69 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.42341248 |
| 70 | histone lysine demethylation (GO:0070076) | 2.42333154 |
| 71 | activation of JUN kinase activity (GO:0007257) | 2.42264197 |
| 72 | histone demethylation (GO:0016577) | 2.42034589 |
| 73 | T cell selection (GO:0045058) | 2.41895620 |
| 74 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40919771 |
| 75 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.40279763 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.40171361 |
| 77 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.37398566 |
| 78 | negative thymic T cell selection (GO:0045060) | 2.35897651 |
| 79 | regulation of regulated secretory pathway (GO:1903305) | 2.35401592 |
| 80 | negative regulation of cell size (GO:0045792) | 2.34303904 |
| 81 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.34044191 |
| 82 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.32245261 |
| 83 | phospholipid scrambling (GO:0017121) | 2.30634024 |
| 84 | negative regulation of innate immune response (GO:0045824) | 2.29597663 |
| 85 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.28653266 |
| 86 | positive regulation of protein deacetylation (GO:0090312) | 2.28317801 |
| 87 | response to laminar fluid shear stress (GO:0034616) | 2.26979869 |
| 88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.26171195 |
| 89 | actin filament polymerization (GO:0030041) | 2.25953236 |
| 90 | negative regulation of interleukin-8 production (GO:0032717) | 2.25828868 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.25775609 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.25554974 |
| 93 | granulocyte activation (GO:0036230) | 2.25512296 |
| 94 | B cell receptor signaling pathway (GO:0050853) | 2.25357598 |
| 95 | macrophage activation (GO:0042116) | 2.24362778 |
| 96 | defense response to protozoan (GO:0042832) | 2.24189637 |
| 97 | peptide catabolic process (GO:0043171) | 2.23104406 |
| 98 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.21647853 |
| 99 | response to manganese ion (GO:0010042) | 2.21388713 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 2.20990396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.98748379 |
| 2 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.66389131 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61678967 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.54735058 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54193251 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.42893992 |
| 7 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.32241681 |
| 8 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.26986655 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.24957469 |
| 10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.24583062 |
| 11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.17718507 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.13754158 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12691027 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96178141 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 1.95511523 |
| 16 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.93728760 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93055861 |
| 18 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.90431999 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87679636 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85805039 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85558247 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82845844 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81335765 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80535489 |
| 25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.78696535 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77353322 |
| 27 | KDM2B_26808549_Chip-Seq_K562_Human | 1.77183034 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74687064 |
| 29 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.70708138 |
| 30 | P68_20966046_ChIP-Seq_HELA_Human | 1.69199977 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68834590 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67786188 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66255195 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65707026 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.65468255 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.65295465 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64876866 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61328379 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.60655315 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.56514007 |
| 41 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.55610410 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.54495651 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54470939 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.52546761 |
| 45 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.52368423 |
| 46 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51490511 |
| 47 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.50062983 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48906771 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47881402 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.46736255 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45319352 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43792542 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43786129 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.42818741 |
| 55 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40957169 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.39984265 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37113143 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.36056726 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34921841 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32243678 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31465101 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27913047 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.27763823 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27619860 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26888185 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26221133 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.25937399 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24899378 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24739776 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24529976 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21593988 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20034745 |
| 73 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.19678335 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19008145 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18141578 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17671303 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17151567 |
| 78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.16171564 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15103930 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11703797 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11052630 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10836240 |
| 83 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10729228 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10311158 |
| 85 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08823728 |
| 86 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08823163 |
| 87 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07329654 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06499093 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05883547 |
| 90 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.05185405 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05173406 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03756152 |
| 93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03498649 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02462295 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00331898 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99339475 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99231822 |
| 98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98868805 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98608284 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98540673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.32996914 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.27422202 |
| 3 | MP0003303_peritoneal_inflammation | 3.01761407 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.95052546 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.77983955 |
| 6 | MP0003724_increased_susceptibility_to | 2.74161830 |
| 7 | MP0005451_abnormal_body_composition | 2.67597524 |
| 8 | MP0008260_abnormal_autophagy | 2.66020840 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.57866795 |
| 10 | MP0008004_abnormal_stomach_pH | 2.29293244 |
| 11 | MP0009278_abnormal_bone_marrow | 2.28250169 |
| 12 | MP0005025_abnormal_response_to | 2.23299431 |
| 13 | MP0002419_abnormal_innate_immunity | 2.22479227 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.21417175 |
| 15 | MP0010155_abnormal_intestine_physiology | 2.14140223 |
| 16 | MP0004947_skin_inflammation | 1.99922918 |
| 17 | MP0001790_abnormal_immune_system | 1.99267660 |
| 18 | MP0005387_immune_system_phenotype | 1.99267660 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.99237586 |
| 20 | MP0001800_abnormal_humoral_immune | 1.88841286 |
| 21 | MP0009785_altered_susceptibility_to | 1.86956261 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.86499104 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.85006866 |
| 24 | MP0005409_darkened_coat_color | 1.83775636 |
| 25 | MP0002723_abnormal_immune_serum | 1.75853260 |
| 26 | MP0000685_abnormal_immune_system | 1.75058150 |
| 27 | MP0005671_abnormal_response_to | 1.70887042 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.68652546 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.68388634 |
| 30 | MP0001819_abnormal_immune_cell | 1.67594526 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.66964008 |
| 32 | MP0002822_catalepsy | 1.64194190 |
| 33 | MP0006082_CNS_inflammation | 1.63444934 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.62362192 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.58841370 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.58204899 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.58080928 |
| 38 | MP0004510_myositis | 1.57208368 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.57100974 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.57100974 |
| 41 | MP0009840_abnormal_foam_cell | 1.53996752 |
| 42 | MP0001849_ear_inflammation | 1.51790238 |
| 43 | MP0004381_abnormal_hair_follicle | 1.49782311 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.47179539 |
| 45 | MP0005377_hearing/vestibular/ear_phenot | 1.44497091 |
| 46 | MP0003878_abnormal_ear_physiology | 1.44497091 |
| 47 | MP0003866_abnormal_defecation | 1.43677876 |
| 48 | MP0002132_abnormal_respiratory_system | 1.42190742 |
| 49 | MP0005310_abnormal_salivary_gland | 1.41772549 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.38979789 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.34289517 |
| 52 | MP0002405_respiratory_system_inflammati | 1.34100750 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.31523980 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.30816116 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.28156962 |
| 56 | MP0002796_impaired_skin_barrier | 1.26021276 |
| 57 | MP0003879_abnormal_hair_cell | 1.25887381 |
| 58 | MP0000716_abnormal_immune_system | 1.25437921 |
| 59 | MP0000858_altered_metastatic_potential | 1.24223691 |
| 60 | MP0002398_abnormal_bone_marrow | 1.22091703 |
| 61 | MP0001958_emphysema | 1.21127510 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.20825224 |
| 63 | MP0005666_abnormal_adipose_tissue | 1.18439149 |
| 64 | MP0002396_abnormal_hematopoietic_system | 1.14596812 |
| 65 | MP0004858_abnormal_nervous_system | 1.14315066 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.13563027 |
| 67 | MP0003045_fibrosis | 1.12754790 |
| 68 | MP0003091_abnormal_cell_migration | 1.09569672 |
| 69 | MP0003690_abnormal_glial_cell | 1.07272764 |
| 70 | MP0000678_abnormal_parathyroid_gland | 1.06575529 |
| 71 | MP0003279_aneurysm | 1.02427859 |
| 72 | MP0001873_stomach_inflammation | 0.98801633 |
| 73 | MP0005375_adipose_tissue_phenotype | 0.97738513 |
| 74 | MP0002249_abnormal_larynx_morphology | 0.97589273 |
| 75 | MP0002722_abnormal_immune_system | 0.96484627 |
| 76 | MP0005257_abnormal_intraocular_pressure | 0.96397050 |
| 77 | MP0000703_abnormal_thymus_morphology | 0.94947009 |
| 78 | MP0002429_abnormal_blood_cell | 0.94281353 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.92626265 |
| 80 | MP0008874_decreased_physiological_sensi | 0.92364181 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.92251502 |
| 82 | MP0008469_abnormal_protein_level | 0.91983174 |
| 83 | MP0004859_abnormal_synaptic_plasticity | 0.90713574 |
| 84 | MP0005166_decreased_susceptibility_to | 0.88702209 |
| 85 | MP0001851_eye_inflammation | 0.88374772 |
| 86 | MP0003828_pulmonary_edema | 0.84197059 |
| 87 | MP0003075_altered_response_to | 0.84125887 |
| 88 | MP0009931_abnormal_skin_appearance | 0.80658255 |
| 89 | MP0000689_abnormal_spleen_morphology | 0.80494362 |
| 90 | MP0001663_abnormal_digestive_system | 0.79913459 |
| 91 | MP0002933_joint_inflammation | 0.78582602 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.77581762 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.75377527 |
| 94 | MP0005390_skeleton_phenotype | 0.74071344 |
| 95 | MP0009764_decreased_sensitivity_to | 0.73618474 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.72690358 |
| 97 | MP0001853_heart_inflammation | 0.72218243 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 0.71364017 |
| 99 | MP0005023_abnormal_wound_healing | 0.66368918 |
| 100 | MP0000490_abnormal_crypts_of | 0.64472351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.01506805 |
| 2 | Obstructive sleep apnea (HP:0002870) | 3.38029149 |
| 3 | Myositis (HP:0100614) | 3.36233332 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.30953557 |
| 5 | Increased IgE level (HP:0003212) | 3.22241918 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.18569331 |
| 7 | Pustule (HP:0200039) | 3.05610539 |
| 8 | Thin bony cortex (HP:0002753) | 3.03480899 |
| 9 | Orchitis (HP:0100796) | 3.03063028 |
| 10 | Abnormality of macrophages (HP:0004311) | 2.99313104 |
| 11 | Cerebral aneurysm (HP:0004944) | 2.96546097 |
| 12 | Broad face (HP:0000283) | 2.89701170 |
| 13 | Gingivitis (HP:0000230) | 2.89296986 |
| 14 | Metaphyseal cupping (HP:0003021) | 2.70572930 |
| 15 | Upper limb amyotrophy (HP:0009129) | 2.66221434 |
| 16 | Distal upper limb amyotrophy (HP:0007149) | 2.66221434 |
| 17 | Optic neuritis (HP:0100653) | 2.66069360 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 2.66069360 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66051921 |
| 20 | Chronic otitis media (HP:0000389) | 2.63400187 |
| 21 | Cervical subluxation (HP:0003308) | 2.62888741 |
| 22 | Abnormality of the fingertips (HP:0001211) | 2.58652733 |
| 23 | Nuclear cataract (HP:0100018) | 2.54924448 |
| 24 | Malnutrition (HP:0004395) | 2.49652816 |
| 25 | Peritonitis (HP:0002586) | 2.47726503 |
| 26 | Hemorrhage of the eye (HP:0011885) | 2.46663290 |
| 27 | Nasal polyposis (HP:0100582) | 2.45638864 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 2.44281267 |
| 29 | Ankle clonus (HP:0011448) | 2.43069467 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 2.38708991 |
| 31 | Cellulitis (HP:0100658) | 2.36178909 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 2.35791336 |
| 33 | Colitis (HP:0002583) | 2.35159909 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.27801997 |
| 35 | Distal lower limb amyotrophy (HP:0008944) | 2.27726217 |
| 36 | Inflammation of the large intestine (HP:0002037) | 2.25861646 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 2.24486294 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.22683699 |
| 39 | Emphysema (HP:0002097) | 2.20548720 |
| 40 | Spondylolisthesis (HP:0003302) | 2.20352731 |
| 41 | J-shaped sella turcica (HP:0002680) | 2.13801842 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13596869 |
| 43 | Obstructive lung disease (HP:0006536) | 2.13596869 |
| 44 | Axonal loss (HP:0003447) | 2.11051363 |
| 45 | Recurrent skin infections (HP:0001581) | 2.09231660 |
| 46 | Neuronal loss in central nervous system (HP:0002529) | 2.08108653 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06937225 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06937225 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06937225 |
| 50 | Meningitis (HP:0001287) | 2.06174330 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.04709381 |
| 52 | Keratoconjunctivitis sicca (HP:0001097) | 2.03439005 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02865062 |
| 54 | Mucopolysacchariduria (HP:0008155) | 1.99925267 |
| 55 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99925267 |
| 56 | Hand muscle atrophy (HP:0009130) | 1.99907211 |
| 57 | Abnormality of the peritoneum (HP:0002585) | 1.97014706 |
| 58 | Prolonged bleeding time (HP:0003010) | 1.96930351 |
| 59 | Vasculitis (HP:0002633) | 1.94992928 |
| 60 | Slow saccadic eye movements (HP:0000514) | 1.94513789 |
| 61 | Hemoptysis (HP:0002105) | 1.92645320 |
| 62 | Premature loss of primary teeth (HP:0006323) | 1.92280672 |
| 63 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91577166 |
| 64 | Chest pain (HP:0100749) | 1.89705931 |
| 65 | Aneurysm (HP:0002617) | 1.88516777 |
| 66 | Hypertriglyceridemia (HP:0002155) | 1.87880555 |
| 67 | Systemic lupus erythematosus (HP:0002725) | 1.86322150 |
| 68 | Flattened epiphyses (HP:0003071) | 1.84353264 |
| 69 | Increased connective tissue (HP:0009025) | 1.83728757 |
| 70 | Easy fatigability (HP:0003388) | 1.83233888 |
| 71 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.82080284 |
| 72 | Hypochromic anemia (HP:0001931) | 1.81451884 |
| 73 | Difficulty climbing stairs (HP:0003551) | 1.80694455 |
| 74 | Gingival bleeding (HP:0000225) | 1.79476787 |
| 75 | Keratoconjunctivitis (HP:0001096) | 1.78435134 |
| 76 | Stridor (HP:0010307) | 1.78434188 |
| 77 | Abnormality of the aortic arch (HP:0012303) | 1.78118818 |
| 78 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77652420 |
| 79 | Polygenic inheritance (HP:0010982) | 1.77537481 |
| 80 | Neurofibrillary tangles (HP:0002185) | 1.76547851 |
| 81 | Fragile skin (HP:0001030) | 1.76480112 |
| 82 | Long palpebral fissure (HP:0000637) | 1.76466429 |
| 83 | Enlarged epiphyses (HP:0010580) | 1.76363677 |
| 84 | Atrophic scars (HP:0001075) | 1.75954520 |
| 85 | Joint stiffness (HP:0001387) | 1.74126835 |
| 86 | Papilledema (HP:0001085) | 1.72992376 |
| 87 | Onion bulb formation (HP:0003383) | 1.72972069 |
| 88 | Pulmonary infiltrates (HP:0002113) | 1.71130741 |
| 89 | Loss of speech (HP:0002371) | 1.70930279 |
| 90 | Biconcave vertebral bodies (HP:0004586) | 1.69121922 |
| 91 | Recurrent bronchitis (HP:0002837) | 1.68676152 |
| 92 | Flat acetabular roof (HP:0003180) | 1.68210717 |
| 93 | Amyloidosis (HP:0011034) | 1.66764678 |
| 94 | Epistaxis (HP:0000421) | 1.65889224 |
| 95 | Thick nail (HP:0001805) | 1.64152326 |
| 96 | Encephalitis (HP:0002383) | 1.61422368 |
| 97 | Thoracic kyphosis (HP:0002942) | 1.60932565 |
| 98 | Joint swelling (HP:0001386) | 1.58006294 |
| 99 | Spinal canal stenosis (HP:0003416) | 1.57656619 |
| 100 | Granulocytopenia (HP:0001913) | 1.57163608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 3.44905945 |
| 2 | ERN1 | 3.22603472 |
| 3 | TRIB3 | 2.89677751 |
| 4 | MST1R | 2.62999371 |
| 5 | TNK2 | 2.62032060 |
| 6 | RIPK4 | 2.54983926 |
| 7 | SIK1 | 2.50111289 |
| 8 | SIK2 | 2.47518657 |
| 9 | MAP4K1 | 2.31279739 |
| 10 | RIPK1 | 2.23272274 |
| 11 | MAP2K3 | 2.19932751 |
| 12 | PRPF4B | 2.03858498 |
| 13 | SIK3 | 1.95367180 |
| 14 | CDK12 | 1.87990883 |
| 15 | TYK2 | 1.72784510 |
| 16 | MARK2 | 1.72455030 |
| 17 | MAP3K7 | 1.60979164 |
| 18 | MAP3K14 | 1.59427438 |
| 19 | BLK | 1.58785188 |
| 20 | EPHB1 | 1.45595722 |
| 21 | ZAP70 | 1.43509737 |
| 22 | MAP3K3 | 1.41696141 |
| 23 | TAOK1 | 1.40225799 |
| 24 | MAP3K6 | 1.39939834 |
| 25 | MAP2K6 | 1.37923882 |
| 26 | IRAK4 | 1.37077283 |
| 27 | EPHA2 | 1.36805037 |
| 28 | LMTK2 | 1.33431368 |
| 29 | PRKD2 | 1.31715793 |
| 30 | TBK1 | 1.31683469 |
| 31 | GRK6 | 1.27946815 |
| 32 | MAP3K11 | 1.21912686 |
| 33 | PKN2 | 1.20555690 |
| 34 | CDC42BPA | 1.18111199 |
| 35 | FGFR4 | 1.17697069 |
| 36 | FES | 1.12833679 |
| 37 | CSK | 1.11074165 |
| 38 | CSF1R | 1.05739276 |
| 39 | FGR | 1.04874247 |
| 40 | MET | 1.04851874 |
| 41 | KSR2 | 1.02921575 |
| 42 | PTK6 | 1.02673987 |
| 43 | ICK | 1.02205218 |
| 44 | JAK3 | 1.01272381 |
| 45 | TESK1 | 0.99527803 |
| 46 | BRD4 | 0.99235870 |
| 47 | MAP3K1 | 0.94545253 |
| 48 | PDPK1 | 0.93333631 |
| 49 | PRKD3 | 0.93223558 |
| 50 | BMX | 0.90417495 |
| 51 | BTK | 0.85988866 |
| 52 | PDK1 | 0.84241281 |
| 53 | HCK | 0.83290966 |
| 54 | STK38 | 0.82697451 |
| 55 | DDR2 | 0.82476634 |
| 56 | JAK1 | 0.80628630 |
| 57 | PDGFRA | 0.79029313 |
| 58 | DAPK2 | 0.76556498 |
| 59 | MATK | 0.70559044 |
| 60 | IKBKE | 0.69245335 |
| 61 | CAMKK1 | 0.69238919 |
| 62 | TAOK2 | 0.68674431 |
| 63 | RPS6KA2 | 0.66353441 |
| 64 | ERBB2 | 0.65631133 |
| 65 | IKBKB | 0.62953345 |
| 66 | RPS6KL1 | 0.62376618 |
| 67 | RPS6KC1 | 0.62376618 |
| 68 | PRKG2 | 0.62307918 |
| 69 | DYRK1B | 0.61014342 |
| 70 | JAK2 | 0.60149505 |
| 71 | TESK2 | 0.58923601 |
| 72 | SMG1 | 0.58694387 |
| 73 | CAMK1D | 0.58329230 |
| 74 | SGK3 | 0.58186115 |
| 75 | PDGFRB | 0.58007062 |
| 76 | PTK2B | 0.57610645 |
| 77 | MTOR | 0.57152058 |
| 78 | WNK1 | 0.55284654 |
| 79 | IRAK3 | 0.55250902 |
| 80 | LCK | 0.53461587 |
| 81 | CHUK | 0.52497925 |
| 82 | TYRO3 | 0.52304592 |
| 83 | MAPK12 | 0.50815567 |
| 84 | BMPR2 | 0.50193913 |
| 85 | NME1 | 0.48367250 |
| 86 | LYN | 0.47484651 |
| 87 | WNK4 | 0.46905250 |
| 88 | KIT | 0.46654665 |
| 89 | PRKCH | 0.46139665 |
| 90 | RPS6KA6 | 0.45425936 |
| 91 | MARK3 | 0.45035334 |
| 92 | HIPK2 | 0.44709213 |
| 93 | RET | 0.44276587 |
| 94 | MAPK7 | 0.43877014 |
| 95 | CAMK1G | 0.41956716 |
| 96 | SYK | 0.41603896 |
| 97 | PRKAA2 | 0.41414240 |
| 98 | FYN | 0.40332548 |
| 99 | FGFR3 | 0.39423837 |
| 100 | TXK | 0.38372217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.47604067 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14646889 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.90672547 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81613625 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.77456011 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72268973 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65032153 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54574075 |
| 9 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.53071320 |
| 10 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.49556076 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48614717 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47333349 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46271314 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42130358 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.37841866 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31591071 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31135145 |
| 18 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.30517172 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.28928269 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26987351 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26210788 |
| 22 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.19549723 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.18459403 |
| 24 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.18371954 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17407732 |
| 26 | Hepatitis C_Homo sapiens_hsa05160 | 1.15542627 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.13366639 |
| 28 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.13356024 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12899236 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11782779 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10502445 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10191686 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08730189 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.06415835 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.06257684 |
| 36 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.04577146 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.03852574 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00098145 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99301878 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97572230 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 0.97322954 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96252765 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94889721 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94223015 |
| 45 | Endocytosis_Homo sapiens_hsa04144 | 0.93926220 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93011921 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92964549 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.92534437 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92054074 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90302899 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90149332 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.89447981 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88829335 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88283890 |
| 55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87738351 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.86780795 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.85938008 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85670609 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85580964 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84197960 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84007594 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83740523 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.82945351 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80700823 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80611841 |
| 66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77631268 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.76541440 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.76027809 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.75142989 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.74457655 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74162877 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.73494183 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.73407332 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73328880 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.72769032 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.72620003 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72215079 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71443170 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70898669 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69877206 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65810306 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65539647 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63718562 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.61326922 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.58878042 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58445895 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.57967647 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.57824926 |
| 89 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57312886 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57174742 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57058995 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56843340 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.56804170 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56111767 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54462957 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54281412 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54188886 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.52624215 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.51003505 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49962871 |

